Clinical Trial Update: Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effect of PTH134 at Increasing Doses in Healthy Postmenopausal Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of escalating doses of PTH134 in healthy postmenopausal women.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• PTH134 (PTH134)

Snippet

Sponsor: Novartis | Conditions: Postmenopausal Osteoporosis | Phase 1 | Status: COMPLETED